Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Anhui, PR China.
Gene. 2013 Sep 15;527(1):95-101. doi: 10.1016/j.gene.2013.05.059. Epub 2013 Jun 4.
Many epidemiological studies have investigated IL1α and IL1β polymorphisms with SLE risk, but no conclusions are available because of conflicting results. This meta-analysis was performed to more precisely estimate the relationships. The databases of PubMed updated to September 1st, 2012 were retrieved. Odds ratio (OR) and corresponding 95% confidence interval (95% CI) as effect size were calculated by a fixed- or random-effect model. In total, six case-control studies for IL1β-511C/T, four studies for IL1β+3953C/T, three studies for IL1α-889C/T and three studies for IL1α+4845G/T were involved in this analysis. The results indicated that for IL1α-889C/T polymorphism T allele was associated with decreased risk of SLE (OR (95% CI)) (T vs. C: 0.802 (0.679-0.949); TT+CT vs. CC: 0.615 (0.380-0.995); TT vs. CC: 0.679 (0.466-0.989)). However, when analysis for TT vs. CT+CC was conducted, the result indicated that IL1α-889C/T polymorphism was not associated with SLE (OR (95% CI): 0.847 (0.595-1.205)). Combined analysis indicated that IL1β-511C/T polymorphism was not overall associated with risk of SLE (OR (95% CI)) (T vs. C: 1.113 (0.954-1.298); TT vs. CT+CC: 1.146 (0.889-1.447); TT+CT vs. CC: 1.145 (0.903-1.452); TT vs. CC: 1.255 (0.928-1.698)). When subgroup analysis for Asian ethnicity was conducted, the results indicated that IL1β-511C/T polymorphism was associated with SLE only for TT vs. CT+CC (OR (95% CI): 1.468 (1.001-2.152)), but was not associated for T vs. C (OR (95% CI): 1.214 (0.955-1.544)), TT+CT vs. CC (OR (95% CI): 1.112 (0.765-1.615)) and TT vs.CC (OR (95% CI): 1.411 (0.896-2.222)). In addition, overall analyses indicated that IL1β+3953C/T and IL1α+4845G/C polymorphisms were also not associated with risk of SLE (OR (95% CI)) (for IL1β+3953C/T T vs. C: 0.996 (0.610-1.626), TT vs. CT+CC: 0.658 (0.318-1.358), TT+CT vs. CC: 1.021 (0.618-1.687), TT vs. CC: 0.640 (0.309-1.325); for IL1α+4845G/T T vs. G: 1.067 (0.791-1.440), TT+GT vs. GG: 0.934 (0.646-1.351)).This study inferred that IL1α-889C/T polymorphism might be moderately associated with SLE, but no sufficient evidence was available to support any associations between IL1β+3953C/T or IL1α+4845G/C polymorphisms and SLE. We could not draw a definite conclusion between IL1β-511C/T polymorphism and risk of SLE owing to the limited data. Further large sample-sized studies should be required.
许多流行病学研究调查了 IL1α 和 IL1β 多态性与 SLE 风险的关系,但由于结果相互矛盾,尚无定论。本荟萃分析旨在更精确地评估这些关系。检索了截止到 2012 年 9 月 1 日的 PubMed 数据库。采用固定或随机效应模型计算比值比(OR)和相应的 95%置信区间(95%CI)作为效应量。共纳入了六项关于 IL1β-511C/T、四项关于 IL1β+3953C/T、三项关于 IL1α-889C/T 和三项关于 IL1α+4845G/T 的病例对照研究。结果表明,对于 IL1α-889C/T 多态性,T 等位基因与 SLE 风险降低相关(OR(95%CI))(T 对 C:0.802(0.679-0.949);TT+CT 对 CC:0.615(0.380-0.995);TT 对 CC:0.679(0.466-0.989))。然而,当分析 TT 对 CT+CC 时,结果表明 IL1α-889C/T 多态性与 SLE 无关(OR(95%CI):0.847(0.595-1.205))。合并分析表明,IL1β-511C/T 多态性与 SLE 风险无总体相关性(OR(95%CI))(T 对 C:1.113(0.954-1.298);TT 对 CT+CC:1.146(0.889-1.447);TT+CT 对 CC:1.145(0.903-1.452);TT 对 CC:1.255(0.928-1.698))。当进行亚洲人群亚组分析时,结果表明,IL1β-511C/T 多态性仅与 TT 对 CT+CC 相关(OR(95%CI):1.468(1.001-2.152)),但与 T 对 C 无关(OR(95%CI):1.214(0.955-1.544))、TT+CT 对 CC(OR(95%CI):1.112(0.765-1.615))和 TT 对 CC(OR(95%CI):1.411(0.896-2.222))。此外,总体分析表明,IL1β+3953C/T 和 IL1α+4845G/C 多态性与 SLE 风险也无关(OR(95%CI))(对于 IL1β+3953C/T,T 对 C:0.996(0.610-1.626),TT 对 CT+CC:0.658(0.318-1.358),TT+CT 对 CC:1.021(0.618-1.687),TT 对 CC:0.640(0.309-1.325);对于 IL1α+4845G/T,T 对 G:1.067(0.791-1.440),TT+GT 对 GG:0.934(0.646-1.351))。本研究推断,IL1α-889C/T 多态性可能与 SLE 中度相关,但没有足够的证据支持 IL1β+3953C/T 或 IL1α+4845G/C 多态性与 SLE 之间的任何关联。由于数据有限,我们不能对 IL1β-511C/T 多态性与 SLE 风险之间的关系得出明确的结论。需要进一步进行大样本量的研究。